retatrutide clinical trial saudi arabia What Is Retatrutide? How Does It Work, and Is It Legal? – SET FOR SET Incretin-based therapies for the treatment

Last Updated: June 2026

Overview Retatrutide is a synthetic, long-acting triple agonist that targets three distinct hormonal receptors: the glucagon-like pep-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor (GCGR)

During this tapering window, intensify dietary structure, increase meal frequency to prevent large hunger spikes, and prioritize protein intakestudies confirm protein consumption amplifies satiety signals that partially compensate for GLP-1 withdrawal

For someone attempting keto, this represents a significant reduction in the friction of adherence